Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

  • There is currently no data for CAU

Trading Update

22 Jan 2025 12:00

RNS Number : 3137U
Centaur Media PLC
22 January 2025
 

Centaur Media plc

Incorporated in England and Wales

Registration number: 04948078

LEI: 2138005WK87G7DQRQI62

ISIN: GB0034291418

 

22 January 2025

Centaur Media Plc

("Centaur" or the "Group")

Trading Update - 2024 performance ahead of consensus

Centaur, an international provider of business intelligence, learning and specialist consultancy, provides a trading update ahead of publishing its results for the full year ended 31 December 2024 ("FY24") in March.

Trading update

Trading, since our last update in October, has been ahead of our outlook and the Board now expects the Group to achieve revenue for FY24 of c. £35m at an adjusted EBITDA1 margin of approximately 16%, ahead of consensus2.

This outcome is despite the marketing sector headwinds in 2024 caused by macro-economic challenges which had a particular impact on the Econsultancy and Oystercatchers brands, as well as Xeim's advertising revenue. Centaur's performance in 2024 was underpinned by growth in revenue from The Lawyer of 7% and from the MW Mini MBA of 5%.

Centaur continues to maintain a robust net cash3 balance of £8.9m as at 31 December 2024 (£8.9m as at 30 June 2024) which will support the maximisation of shareholder value.

As highlighted in December, a review of Centaur's business operations and strategy is currently underway.

Martin Rowland, Executive Chair, commented:

"It is pleasing to see the Group's performance showing better than expected results for 2024. Since taking on the role of Executive Chair earlier this month, I have started a review of Centaur's business units and their brands. Our focus will be on defining the strategy and enhancing the reputation of each brand within Centaur to maximise shareholder value while remaining our customers' partner of choice for business intelligence and learning in the marketing and legal sectors."

 

-Ends-

 

1 Adjusted EBITDA is adjusted operating profit before depreciation and amortisation. Adjusted results exclude adjusting items, such as amortisation of acquired intangible assets, as detailed in note 4 of the Interim Report for the period ended 30 June 2024.

2 Consensus from the analysts' latest coverage following the October trading update was revenue of £34.0m and adjusted EBITDA of £5.1m, an adjusted EBITDA margin of 15%.

3 Net cash is the total of cash and cash equivalents and short-term deposits. There are no overdrafts or borrowings in the Group.

 

Enquiries

Centaur Media Plc

020 7970 4000

Martin Rowland, Executive Chair

Simon Longfield, Chief Financial Officer

Teneo

Zoë Watt

07713 157561

 

Note to editors

Centaur is an international provider of business intelligence, learning and specialist consultancy that helps ambitious leaders see around corners and deliver change in the Marketing and Legal verticals. Our suite of brands includes The Lawyer, MW Mini MBA, Econsultancy, Marketing Week, Festival of Marketing and Influencer Intelligence that provide deep sector expertise across the Legal and Marketing industries based on our customers' needs.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEAFFEEISEDF
Date   Source Headline
18th Apr 202311:47 amRNSDirector/PDMR Shareholding
12th Apr 20232:41 pmRNSDirector/PDMR Shareholding
4th Apr 20231:48 pmRNSAnnual Financial Report
21st Mar 20239:51 amRNSHolding(s) in Company
20th Mar 20233:33 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
20th Feb 20239:30 amRNSDirector/PDMR Shareholding
31st Jan 20239:01 amRNSHolding(s) in Company
23rd Jan 20239:25 amRNSDirector/PDMR Shareholding
19th Jan 20237:00 amRNSTrading Update & Declaration of a Special Dividend
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
20th Dec 20222:19 pmRNSDirector/PDMR Shareholding
22nd Nov 20221:52 pmRNSDirector/PDMR Shareholding
16th Nov 20223:57 pmRNSDirector/PDMR Shareholding
24th Oct 20229:37 amRNSDirector/PDMR Shareholding
23rd Sep 202211:24 amRNSDirector/PDMR Shareholding
22nd Aug 20227:00 amRNSDirector/PDMR Shareholding
25th Jul 20225:13 pmRNSDirector/PDMR Shareholding
25th Jul 20229:50 amRNSDirector/PDMR Shareholding
20th Jul 20227:00 amRNSInterim Results
5th Jul 202210:30 amRNSDirector/PDMR Shareholding
23rd May 202210:33 amRNSDirector/PDMR Shareholding
16th May 20227:00 amRNSNon-Executive Director Appointment
12th May 202211:08 amRNSDirector/PDMR Shareholding
11th May 20223:09 pmRNSResult of AGM
21st Apr 202211:27 amRNSDirector/PDMR Shareholding
1st Apr 202211:54 amRNSAnnual Financial Report
25th Mar 202211:32 amRNSDirector/PDMR Shareholding
22nd Mar 20223:24 pmRNSDirector/PDMR Shareholding
18th Mar 20229:35 amRNSDirector/PDMR Shareholding
18th Mar 20229:31 amRNSHolding(s) in Company
16th Mar 20227:00 amRNSPreliminary results
22nd Feb 20223:03 pmRNSDirector/PDMR Shareholding
20th Jan 202210:59 amRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSTrading Update
21st Dec 20214:31 pmRNSDirector/PDMR Shareholding
22nd Nov 202111:24 amRNSDirector/PDMR Shareholding
12th Nov 20219:54 amRNSHolding(s) in Company
12th Nov 20219:52 amRNSHolding(s) in Company
10th Nov 202110:11 amRNSNotification of major holdings
1st Nov 20214:18 pmRNSHolding(s) in Company
1st Nov 20211:46 pmRNSHolding(s) in Company
1st Nov 202110:37 amRNSHolding(s) in Company
1st Nov 202110:33 amRNSHolding(s) in Company
20th Oct 202111:54 amRNSDirector/PDMR Shareholding
13th Oct 20217:00 amRNSTrading Update
6th Oct 20219:30 amRNSHolding(s) in Company
21st Sep 202110:31 amRNSDirector/PDMR Shareholding
7th Sep 202112:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.